» Articles » PMID: 29228445

The Protective Effect and Its Mechanism of 3-n-butylphthalide Pretreatment on Cerebral Ischemia Reperfusion Injury in Rats

Overview
Date 2017 Dec 12
PMID 29228445
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the potential effect of 3-n-butylphthalide (NBP) pretreatment on the cerebral ischemia/reperfusion injury in rats and the relevant mechanism.

Materials And Methods: A total of 90 rats was divided into three groups: Sham operation group (Sham group), ischemia-reperfusion group (I-R group), and NBP pretreatment group (NBP group 75 mg·kg-1·d-1 gavage). Pre-treatment was given once a day within 1 week before establishing the rat model of cerebral ischemia-reperfusion injury. The middle cerebral artery occlusion (MACO) rat models were established with the improved Longa-Zea method on the 7th day after ischemia for 2 h and reperfusion for 24 h in all the rats. We detected the cerebral infarction, the pathologic change of brain, the apoptosis of nerve cell, the production levels of reactive oxygen species (ROS), the content of malonaldehyde (MDA) and the activity of superoxide dismutase (SOD), the water content and the permeability of blood-brain barriers (BBB). In addition, we also observed the expressions of mitogen-activated protein kinase (MAPK, p-38, JNK, ERK1/2) and cleaved caspase-3 in the hippocampus tissues.

Results: Compared with Sham group, we discovered that NBP significantly reduced infarction area, cell apoptosis, BBB damage and water content. Further, we found that NBP could also decrease ROS and MDA, and increase SOD activity in brain tissues of rats with a cerebral ischemia-reperfusion injury. Moreover, results showed that NBP also inhibited the levels p38 and JNK.

Conclusions: NBP protected the cerebral from I/R injury, providing ideas for the expansion of clinical adaptability of NBP and possible approaches for its application.

Citing Articles

Efficacy and safety of DL-3-N-butylphthalide in the treatment of ischemic poststroke aphasia: A randomized clinical trial.

Tian J, Yang P, Yang J, Wang R, Zhou B, Zhang K Ann Clin Transl Neurol. 2024; 11(12):3300-3309.

PMID: 39575649 PMC: 11651212. DOI: 10.1002/acn3.52238.


3-N-Butylphthalide Confers Antiarrhythmic Features in Ischemia/Reperfusion Injury of Diabetic Heart by Targeting Mitochondria-Endoplasmic Reticulum Network and Inhibiting Oxidative Stress and Inflammation.

Han R, Duan B Physiol Res. 2024; 73(4):529-541.

PMID: 39264076 PMC: 11414586.


Indole-3-carbinol (I3C) reduces apoptosis and improves neurological function after cerebral ischemia-reperfusion injury by modulating microglia inflammation.

Peng L, Zhu X, Wang C, Jiang Q, Yu S, Song G Sci Rep. 2024; 14(1):3145.

PMID: 38326384 PMC: 10850550. DOI: 10.1038/s41598-024-53636-6.


Astrocyte-Derived Extracellular Vesicles for Ischemic Stroke: Therapeutic Potential and Prospective.

Wang X, Li A, Fan H, Li Y, Yang N, Tang Y Aging Dis. 2023; 15(3):1227-1254.

PMID: 37728588 PMC: 11081164. DOI: 10.14336/AD.2023.0823-1.


Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway.

Duan Q, Wu J Open Med (Wars). 2023; 18(1):20230698.

PMID: 37415610 PMC: 10320570. DOI: 10.1515/med-2023-0698.